Pilot study on the use of fluorescence imaging of second echelon lymph nodes during melanoma sentinel node procedure, using indocyanine green

Pilot study on the use of fluorescence imaging of second echelon lymph nodes during melanoma sentinel node procedure, using indocyanine green - Intraoperative lymphatic mapping using ICG in melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57813

Enrollment

Registered

2010-11-25

Start date

2010-11-15

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanomen malignant melanoma Skin cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Histoloy proven melanoma - Any histological grade - Scheduled for SLN biopsie

Exclusion criteria

Exclusion criteria: - History of allergy to iodides (www.fda.gov) - Hyperthyroid or autonomic thyroidal adenoma - Kidney insufficiency - Pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Primary: visualisation of the lymph nodes other than the sentinel lymph node.	—

Secondary

Measure	Time frame
Niet van toepassing.	—

Countries

Netherlands

Outcome results